Statements of Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Statements of Comprehensive Loss [Abstract]
Sales	$ 1,071,970	$ 1,206,218
Cost of sales (excluding depreciation expense)	380,069	441,938
Operating expenses:
Research and development	7,208,701	5,813,755
Sales and marketing	650,126	558,852
General and administrative	6,858,008	5,430,704
Depreciation and amortization	483,481	561,233
Total operating expenses	15,200,316	12,364,544
Loss from operations	(14,508,415)	(11,600,264)
Other income (expense):
Interest income	431,019	228,164
Interest expense	(165,390)	(13,464)
Other expense	0	(2,306)
Total other income	265,629	212,394
Loss before income taxes	(14,242,786)	(11,387,870)
Income tax expense	4,338	6,300
Net loss	(14,247,124)	(11,394,170)
Net loss attributable to common stockholders, basic	(14,247,124)	(11,394,170)
Net loss attributable to common stockholders, diluted	$ (14,247,124)	$ (11,394,170)
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.93)	$ (0.96)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.93)	$ (0.96)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)	15,384,376	11,815,019
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	15,384,376	11,815,019